To our knowledge, this is the first report linking miR-1911-3p to NSCLC and more importantly, linking miR-1911-3p to suppressing mTOR signaling through MEAK7. Thus it will be important to determine if manipulation of miR-1911-3p expression could have a potential therapeutic application in lung cancer. The gene discussed is MTOR; the disease is non-small cell lung carcinoma.